Accurate identification of snoRNA targets using variational graph autoencoder to advance the redevelopment of traditional medicines

Existing studies indicate that dysregulation or abnormal expression of small nucleolar RNA (snoRNA) is closely associated with various diseases, including lung cancer. Furthermore, these diseases often involve multiple targets, making the redevelopment of traditional medicines highly promising. Accu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in pharmacology Jg. 15; S. 1529128
Hauptverfasser: Wang, Zhina, Chen, Yangyuan, Ma, Hongming, Gao, Hong, Zhu, Yangbin, Wang, Hongwu, Zhang, Nan
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland Frontiers Media S.A 06.01.2025
Schlagworte:
ISSN:1663-9812, 1663-9812
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Existing studies indicate that dysregulation or abnormal expression of small nucleolar RNA (snoRNA) is closely associated with various diseases, including lung cancer. Furthermore, these diseases often involve multiple targets, making the redevelopment of traditional medicines highly promising. Accurate prediction of potential snoRNA therapeutic targets is essential for early disease intervention and the redevelopment of traditional medicines. Additionally, researchers have developed artificial intelligence (AI)-based methods to screen and predict potential snoRNA therapeutic targets, thereby advancing traditional drug redevelopment. However, existing methods face challenges such as imbalanced datasets and the dominance of high-degree nodes in graph neural networks (GNNs), which compromise the accuracy of node representations. To address these challenges, we propose an AI model based on variational graph autoencoders (VGAEs) that integrates decoupling and Kolmogorov-Arnold Network (KAN) technologies. The model reconstructs snoRNA-disease graphs by learning snoRNA and disease representations, accurately identifying potential snoRNA therapeutic targets. By decoupling similarity from node degree, the model mitigates the dominance of high-degree nodes, enhances prediction accuracy in scenarios like lung cancer, and leverages KAN technology to improve adaptability and flexibility to new data. Case studies revealed that snoRNA SNORA21 and SNORD33 are abnormally expressed in lung cancer patients and are strong candidates for potential therapeutic targets. These findings validate the proposed model’s effectiveness in identifying therapeutic targets for diseases like lung cancer, supporting early screening and treatment, and advancing the redevelopment of traditional medicines. Data and experimental findings are archived in: https://github.com/shmildsj/data .
AbstractList Existing studies indicate that dysregulation or abnormal expression of small nucleolar RNA (snoRNA) is closely associated with various diseases, including lung cancer. Furthermore, these diseases often involve multiple targets, making the redevelopment of traditional medicines highly promising. Accurate prediction of potential snoRNA therapeutic targets is essential for early disease intervention and the redevelopment of traditional medicines. Additionally, researchers have developed artificial intelligence (AI)-based methods to screen and predict potential snoRNA therapeutic targets, thereby advancing traditional drug redevelopment. However, existing methods face challenges such as imbalanced datasets and the dominance of high-degree nodes in graph neural networks (GNNs), which compromise the accuracy of node representations. To address these challenges, we propose an AI model based on variational graph autoencoders (VGAEs) that integrates decoupling and Kolmogorov-Arnold Network (KAN) technologies. The model reconstructs snoRNA-disease graphs by learning snoRNA and disease representations, accurately identifying potential snoRNA therapeutic targets. By decoupling similarity from node degree, the model mitigates the dominance of high-degree nodes, enhances prediction accuracy in scenarios like lung cancer, and leverages KAN technology to improve adaptability and flexibility to new data. Case studies revealed that snoRNA SNORA21 and SNORD33 are abnormally expressed in lung cancer patients and are strong candidates for potential therapeutic targets. These findings validate the proposed model’s effectiveness in identifying therapeutic targets for diseases like lung cancer, supporting early screening and treatment, and advancing the redevelopment of traditional medicines. Data and experimental findings are archived in: https://github.com/shmildsj/data.
Existing studies indicate that dysregulation or abnormal expression of small nucleolar RNA (snoRNA) is closely associated with various diseases, including lung cancer. Furthermore, these diseases often involve multiple targets, making the redevelopment of traditional medicines highly promising. Accurate prediction of potential snoRNA therapeutic targets is essential for early disease intervention and the redevelopment of traditional medicines. Additionally, researchers have developed artificial intelligence (AI)-based methods to screen and predict potential snoRNA therapeutic targets, thereby advancing traditional drug redevelopment. However, existing methods face challenges such as imbalanced datasets and the dominance of high-degree nodes in graph neural networks (GNNs), which compromise the accuracy of node representations. To address these challenges, we propose an AI model based on variational graph autoencoders (VGAEs) that integrates decoupling and Kolmogorov-Arnold Network (KAN) technologies. The model reconstructs snoRNA-disease graphs by learning snoRNA and disease representations, accurately identifying potential snoRNA therapeutic targets. By decoupling similarity from node degree, the model mitigates the dominance of high-degree nodes, enhances prediction accuracy in scenarios like lung cancer, and leverages KAN technology to improve adaptability and flexibility to new data. Case studies revealed that snoRNA SNORA21 and SNORD33 are abnormally expressed in lung cancer patients and are strong candidates for potential therapeutic targets. These findings validate the proposed model's effectiveness in identifying therapeutic targets for diseases like lung cancer, supporting early screening and treatment, and advancing the redevelopment of traditional medicines. Data and experimental findings are archived in: https://github.com/shmildsj/data.Existing studies indicate that dysregulation or abnormal expression of small nucleolar RNA (snoRNA) is closely associated with various diseases, including lung cancer. Furthermore, these diseases often involve multiple targets, making the redevelopment of traditional medicines highly promising. Accurate prediction of potential snoRNA therapeutic targets is essential for early disease intervention and the redevelopment of traditional medicines. Additionally, researchers have developed artificial intelligence (AI)-based methods to screen and predict potential snoRNA therapeutic targets, thereby advancing traditional drug redevelopment. However, existing methods face challenges such as imbalanced datasets and the dominance of high-degree nodes in graph neural networks (GNNs), which compromise the accuracy of node representations. To address these challenges, we propose an AI model based on variational graph autoencoders (VGAEs) that integrates decoupling and Kolmogorov-Arnold Network (KAN) technologies. The model reconstructs snoRNA-disease graphs by learning snoRNA and disease representations, accurately identifying potential snoRNA therapeutic targets. By decoupling similarity from node degree, the model mitigates the dominance of high-degree nodes, enhances prediction accuracy in scenarios like lung cancer, and leverages KAN technology to improve adaptability and flexibility to new data. Case studies revealed that snoRNA SNORA21 and SNORD33 are abnormally expressed in lung cancer patients and are strong candidates for potential therapeutic targets. These findings validate the proposed model's effectiveness in identifying therapeutic targets for diseases like lung cancer, supporting early screening and treatment, and advancing the redevelopment of traditional medicines. Data and experimental findings are archived in: https://github.com/shmildsj/data.
Existing studies indicate that dysregulation or abnormal expression of small nucleolar RNA (snoRNA) is closely associated with various diseases, including lung cancer. Furthermore, these diseases often involve multiple targets, making the redevelopment of traditional medicines highly promising. Accurate prediction of potential snoRNA therapeutic targets is essential for early disease intervention and the redevelopment of traditional medicines. Additionally, researchers have developed artificial intelligence (AI)-based methods to screen and predict potential snoRNA therapeutic targets, thereby advancing traditional drug redevelopment. However, existing methods face challenges such as imbalanced datasets and the dominance of high-degree nodes in graph neural networks (GNNs), which compromise the accuracy of node representations. To address these challenges, we propose an AI model based on variational graph autoencoders (VGAEs) that integrates decoupling and Kolmogorov-Arnold Network (KAN) technologies. The model reconstructs snoRNA-disease graphs by learning snoRNA and disease representations, accurately identifying potential snoRNA therapeutic targets. By decoupling similarity from node degree, the model mitigates the dominance of high-degree nodes, enhances prediction accuracy in scenarios like lung cancer, and leverages KAN technology to improve adaptability and flexibility to new data. Case studies revealed that snoRNA SNORA21 and SNORD33 are abnormally expressed in lung cancer patients and are strong candidates for potential therapeutic targets. These findings validate the proposed model’s effectiveness in identifying therapeutic targets for diseases like lung cancer, supporting early screening and treatment, and advancing the redevelopment of traditional medicines. Data and experimental findings are archived in: https://github.com/shmildsj/data .
Author Chen, Yangyuan
Ma, Hongming
Gao, Hong
Wang, Hongwu
Zhang, Nan
Wang, Zhina
Zhu, Yangbin
AuthorAffiliation 1 Department of Pulmonary and Critical Care Medicine II , Emergency General Hospital , Beijing , China
3 School of Data Science and Artificial Intelligence , Wenzhou University of Technology , Wenzhou , China
4 Respiratory Disease Center , Dongzhimen Hospital , Beijing University of Chinese Medicine , Beijing , China
2 Department of Oncology , Emergency General Hospital , Beijing , China
AuthorAffiliation_xml – name: 4 Respiratory Disease Center , Dongzhimen Hospital , Beijing University of Chinese Medicine , Beijing , China
– name: 1 Department of Pulmonary and Critical Care Medicine II , Emergency General Hospital , Beijing , China
– name: 2 Department of Oncology , Emergency General Hospital , Beijing , China
– name: 3 School of Data Science and Artificial Intelligence , Wenzhou University of Technology , Wenzhou , China
Author_xml – sequence: 1
  givenname: Zhina
  surname: Wang
  fullname: Wang, Zhina
– sequence: 2
  givenname: Yangyuan
  surname: Chen
  fullname: Chen, Yangyuan
– sequence: 3
  givenname: Hongming
  surname: Ma
  fullname: Ma, Hongming
– sequence: 4
  givenname: Hong
  surname: Gao
  fullname: Gao, Hong
– sequence: 5
  givenname: Yangbin
  surname: Zhu
  fullname: Zhu, Yangbin
– sequence: 6
  givenname: Hongwu
  surname: Wang
  fullname: Wang, Hongwu
– sequence: 7
  givenname: Nan
  surname: Zhang
  fullname: Zhang, Nan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39834830$$D View this record in MEDLINE/PubMed
BookMark eNp9kktvEzEUhUeoiD7oH2CBvGSTMB4_Yq9QVAGtVIGEYG3dse8kriZ2sD2RWPPHcR5FLQu8sC37nO_q6p7L5izEgE3zhrZzxpR-P2zXkOZd2_E5FZ2mnXrRXFAp2Uwr2p09uZ831zk_tHUxrZnkr5pzphXjirUXze-ltVOCgsQ7DMUP3kLxMZA4kBzity9LUiCtsGQyZR9WZAfJHxQwklWC7ZrAVCIGGx0mUiIBt4NgkZQ1koQOdzjG7aay98iSwPmTe4POWx8wv25eDjBmvD6dV82PTx-_39zO7r9-vrtZ3s8sl7rMpHRcurbvAQcqKKq2twppayVKEBwtglYddlpqoSzlTjvNYZBsQRGqkl01d0eui_BgtslvIP0yEbw5PMS0MpCKtyMaKwTDwXIlO8ndYIHVnfU9IudW9rayPhxZ26mvjdjaX4LxGfT5T_Brs4o7Q-mCM6kWlfDuREjx54S5mI3PFscRAsYpG0bFQggphK7St0-L_a3yOMYqUEeBTTHnhIOxvhymVGv70dDW7ENjDqEx-9CYU2iqtfvH-kj_j-kPBKbLYw
CitedBy_id crossref_primary_10_1093_bib_bbaf453
Cites_doi 10.1080/15476286.2020.1737441
10.1093/bib/bbad129
10.1093/bib/bbae127
10.1093/nar/gkac814
10.1093/bib/bbac339
10.1186/s13046-015-0170-5
10.1016/j.bbcan.2012.03.005
10.1109/CVPR.2018.00534
10.1093/bib/bbae179
10.1093/bib/bbae078
10.18653/v1/2020.emnlp-main.574
10.1038/srep18614
10.1016/s0092-8674(00)81308-2
10.1016/j.omtn.2024.102187
10.1186/s12915-024-02028-3
10.1016/j.compbiomed.2023.107143
10.1186/1476-4598-9-198
10.1016/j.omtn.2023.102103
10.1007/s12094-024-03606-1
10.1093/bib/bbad227
10.1109/JBHI.2024.3496294
10.1093/bib/bbad483
10.1371/journal.pcbi.1010671
10.1093/bib/bbad247
10.1109/TCBB.2022.3204726
10.1093/bfgp/elae005
10.1145/3589334.3645601
10.1109/CVPR.2017.713
10.1093/nar/gkaa707
10.1093/bib/bbad094
10.1093/bib/bbac240
10.1016/j.ijbiomac.2024.133825
10.1016/j.gendis.2022.11.018
10.1109/jbhi.2024.3510297
10.1109/JBHI.2021.3088342
10.1093/bioinformatics/btae271
10.1016/j.compbiomed.2024.108104
10.1145/3459637.3482215
10.1126/science.1118265
10.1016/j.future.2024.05.055
10.1021/acs.jpclett.4c01509
10.1371/journal.pcbi.1012400
10.1186/s12864-023-09802-7
10.1016/j.compbiomed.2024.108484
10.1371/journal.pone.0162622
10.1021/acs.jcim.3c00868
10.1016/0169-7439(89)80095-4
10.1038/nrg3074
10.1016/j.compbiomed.2023.106783
10.3389/fmicb.2023.1170559
10.1093/bioinformatics/btz965
10.1038/s41540-023-00267-8
10.1093/bioinformatics/btae438
10.3389/fonc.2019.00788
ContentType Journal Article
Copyright Copyright © 2025 Wang, Chen, Ma, Gao, Zhu, Wang and Zhang.
Copyright © 2025 Wang, Chen, Ma, Gao, Zhu, Wang and Zhang. 2025 Wang, Chen, Ma, Gao, Zhu, Wang and Zhang
Copyright_xml – notice: Copyright © 2025 Wang, Chen, Ma, Gao, Zhu, Wang and Zhang.
– notice: Copyright © 2025 Wang, Chen, Ma, Gao, Zhu, Wang and Zhang. 2025 Wang, Chen, Ma, Gao, Zhu, Wang and Zhang
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fphar.2024.1529128
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Wang et al
EISSN 1663-9812
ExternalDocumentID oai_doaj_org_article_c553efc486264dfca34df3bbee44c6bc
PMC11743687
39834830
10_3389_fphar_2024_1529128
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
ACXDI
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c469t-66d46d0bbaef151e80bc8e10c6e6a54ecea982e296958c14d9d94af6371eac8e3
IEDL.DBID DOA
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001399371700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1663-9812
IngestDate Fri Oct 03 12:51:52 EDT 2025
Tue Sep 30 17:06:14 EDT 2025
Thu Sep 04 16:17:17 EDT 2025
Thu Jan 30 12:30:00 EST 2025
Sat Nov 29 02:27:38 EST 2025
Tue Nov 18 22:41:43 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords lung cancer
snoRNA therapeutic targets
redevelopment of traditional medicines
artificial intelligence (AI)
variational graph autoencoder (VGAE)
Language English
License Copyright © 2025 Wang, Chen, Ma, Gao, Zhu, Wang and Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-66d46d0bbaef151e80bc8e10c6e6a54ecea982e296958c14d9d94af6371eac8e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Xiong Li, East China Jiaotong University, China
Reviewed by: Xiangzheng Fu, Hunan University, China
Edited by: Junlin Xu, Hunan University, China
OpenAccessLink https://doaj.org/article/c553efc486264dfca34df3bbee44c6bc
PMID 39834830
PQID 3157556559
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_c553efc486264dfca34df3bbee44c6bc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11743687
proquest_miscellaneous_3157556559
pubmed_primary_39834830
crossref_citationtrail_10_3389_fphar_2024_1529128
crossref_primary_10_3389_fphar_2024_1529128
PublicationCentury 2000
PublicationDate 2025-01-06
PublicationDateYYYYMMDD 2025-01-06
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-06
  day: 06
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2025
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Sun (B31) 2022; 23
Wang (B34); 276
Wei (B43); 157
Zhao (B50) 2022; 20
Esteller (B5) 2011; 12
Wang (B32); 25
Hou (B6) 2022; 18
Kipf (B8) 2016
Liu (B20) 2017
Zhang (B46); 17
Ranjan (B29) 2017
Zheng (B52) 2018
Zhang (B48) 2023; 10
Zhou (B56); 35
Ning (B26) 2021; 49
Ning (B27) 2023; 24
Zhang (B47); 35
Ma (B23); 40
Zhuo (B59) 2023; 24
Cho (B3) 2024
Liu (B22) 2024
Liu (B21); 24
Qi (B28) 2016; 6
Li (B13) 2020; 36
Liu (B19); 24
Krishnan (B12) 2016; 11
Kishore (B9) 2006; 311
Kiss-László (B10) 1996; 85
Zhou (B54) 2023; 163
Zheng (B51) 2015; 34
Chen (B2) 2023; 51
Liao (B17) 2010; 9
Wei (B44); 24
Zhang (B45); 33
Zhou (B57); 25
Mannoor (B25) 2012; 1826
Zhuo (B58) 2022; 23
Wang (B35); 25
Ahn (B1) 2021
Ma (B24); 174
Wei (B40)
Ding (B4) 2021; 26
Wei (B41); 15
Zhou (B55); 40
Wei (B39); 171
Li (B15) 2023; 9
Liao (B18) 2023; 14
Zhang (B49)
St (B30) 1989; 6
Zhou (B53); 23
Wang (B33); 64
Wang (B37) 2019; 9
Hu (B7) 2024; 25
Li (B16); 160
Wang (B36); 20
Wang (B38)
Kobayashi (B11) 2020
Wei (B42); 22
Li (B14)
References_xml – volume: 17
  start-page: 943
  ident: B46
  article-title: ncRPheno: a comprehensive database platform for identification and validation of disease related noncoding RNAs
  publication-title: RNA Biol.
  doi: 10.1080/15476286.2020.1737441
– volume: 24
  start-page: bbad129
  ident: B21
  article-title: NSRGRN: a network structure refinement method for gene regulatory network inference
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbad129
– volume-title: L2-constrained softmax loss for discriminative face verification
  year: 2017
  ident: B29
– volume: 25
  start-page: bbae127
  ident: B35
  article-title: MS-BACL: enhancing metabolic stability prediction through bond graph augmentation and contrastive learning
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbae127
– volume: 51
  start-page: D1397
  year: 2023
  ident: B2
  article-title: RNADisease v4. 0: an updated resource of RNA-associated diseases, providing RNA-disease analysis, enrichment and prediction
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkac814
– volume: 23
  start-page: bbac339
  year: 2022
  ident: B58
  article-title: Predicting ncRNA–protein interactions based on dual graph convolutional network and pairwise learning
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbac339
– volume: 34
  start-page: 49
  year: 2015
  ident: B51
  article-title: Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancer
  publication-title: J. Exp. and Clin. Cancer Res.
  doi: 10.1186/s13046-015-0170-5
– volume: 1826
  start-page: 121
  year: 2012
  ident: B25
  article-title: Small nucleolar RNAs in cancer
  publication-title: Biochimica Biophysica Acta (BBA)-Reviews Cancer
  doi: 10.1016/j.bbcan.2012.03.005
– volume-title: Proceedings of the IEEE conference on computer vision and pattern recognition
  year: 2018
  ident: B52
  article-title: Ring loss: convex feature normalization for face recognition
  doi: 10.1109/CVPR.2018.00534
– volume: 25
  start-page: bbae179
  year: 2024
  ident: B7
  article-title: IGCNSDA: unraveling disease-associated snoRNAs with an interpretable graph convolutional network
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbae179
– volume-title: Variational graph auto-encoders
  year: 2016
  ident: B8
– volume: 25
  start-page: bbae078
  ident: B32
  article-title: Diff-AMP: tailored designed antimicrobial peptide framework with all-in-one generation, identification, prediction and optimization
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbae078
– volume-title: 2020 conference on empirical methods in natural language processing, EMNLP 2020
  year: 2020
  ident: B11
  article-title: Attention is not only a weight: analyzing transformers with vector norms
  doi: 10.18653/v1/2020.emnlp-main.574
– volume: 6
  start-page: 18614
  year: 2016
  ident: B28
  article-title: Snord116 is critical in the regulation of food intake and body weight
  publication-title: Sci. Rep.
  doi: 10.1038/srep18614
– volume: 85
  start-page: 1077
  year: 1996
  ident: B10
  article-title: Site-specific ribose methylation of preribosomal RNA: a novel function for small nucleolar RNAs
  publication-title: Cell
  doi: 10.1016/s0092-8674(00)81308-2
– volume: 35
  start-page: 102187
  ident: B47
  article-title: Fusion of multi-source relationships and topology to infer lncRNA-protein interactions
  publication-title: Mol. Therapy-Nucleic Acids
  doi: 10.1016/j.omtn.2024.102187
– volume: 22
  start-page: 226
  ident: B42
  article-title: DrugReAlign: a multisource prompt framework for drug repurposing based on large language models
  publication-title: BMC Biol.
  doi: 10.1186/s12915-024-02028-3
– volume: 163
  start-page: 107143
  year: 2023
  ident: B54
  article-title: MHAM-NPI: predicting ncRNA-protein interactions based on multi-head attention mechanism
  publication-title: Comput. Biol. Med.
  doi: 10.1016/j.compbiomed.2023.107143
– volume: 9
  start-page: 198
  year: 2010
  ident: B17
  article-title: Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
  publication-title: Mol. cancer
  doi: 10.1186/1476-4598-9-198
– volume: 35
  start-page: 102103
  ident: B56
  article-title: Joint masking and self-supervised strategies for inferring small molecule-miRNA associations
  publication-title: Mol. Therapy-Nucleic Acids
  doi: 10.1016/j.omtn.2023.102103
– start-page: 1
  ident: B14
  article-title: The diagnostic value of serum exosomal SNORD116 and SNORA21 for NSCLC patients
  publication-title: Clin. Transl. Oncol.
  doi: 10.1007/s12094-024-03606-1
– volume: 24
  start-page: bbad227
  ident: B19
  article-title: MPCLCDA: predicting circRNA–disease associations by using automatically selected meta-path and contrastive learning
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbad227
– start-page: 1
  ident: B40
  article-title: BloodPatrol: revolutionizing blood cancer diagnosis - advanced real-time detection leveraging deep learning and cloud technologies
  publication-title: IEEE J. Biomed. health Inf.
  doi: 10.1109/JBHI.2024.3496294
– volume: 25
  start-page: bbad483
  ident: B57
  article-title: Joint deep autoencoder and subgraph augmentation for inferring microbial responses to drugs
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbad483
– volume: 18
  start-page: e1010671
  year: 2022
  ident: B6
  article-title: iPiDA-GCN: identification of piRNA-disease associations based on Graph Convolutional Network
  publication-title: PLOS Comput. Biol.
  doi: 10.1371/journal.pcbi.1010671
– volume: 24
  start-page: bbad247
  ident: B44
  article-title: GCFMCL: predicting miRNA-drug sensitivity using graph collaborative filtering and multi-view contrastive learning
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbad247
– volume: 20
  start-page: 1298
  year: 2022
  ident: B50
  article-title: Predicting Mirna-disease associations based on neighbor selection graph attention networks
  publication-title: IEEE/ACM Trans. Comput. Biol. Bioinforma.
  doi: 10.1109/TCBB.2022.3204726
– volume: 23
  start-page: 475
  ident: B53
  article-title: GAM-MDR: probing miRNA-drug resistance using a graph autoencoder based on random path masking
  publication-title: Briefings Funct. Genomics
  doi: 10.1093/bfgp/elae005
– volume-title: Proceedings of the ACM on web conference 2024
  year: 2024
  ident: B3
  article-title: Decoupled variational graph autoencoder for link prediction
  doi: 10.1145/3589334.3645601
– volume: 33
  start-page: 18772
  ident: B45
  article-title: Deep metric learning with spherical embedding
  publication-title: Adv. Neural Inf. Process. Syst.
– volume-title: Proceedings of the IEEE conference on computer vision and pattern recognition
  year: 2017
  ident: B20
  article-title: Sphereface: deep hypersphere embedding for face recognition
  doi: 10.1109/CVPR.2017.713
– volume: 49
  start-page: D160
  year: 2021
  ident: B26
  article-title: MNDR v3. 0: mammal ncRNA–disease repository with increased coverage and annotation
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkaa707
– volume: 24
  start-page: bbad094
  year: 2023
  ident: B27
  article-title: AMHMDA: attention aware multi-view similarity networks and hypergraph learning for miRNA–disease associations identification
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbad094
– volume: 23
  start-page: bbac240
  year: 2022
  ident: B31
  article-title: PSnoD: identifying potential snoRNA-disease associations based on bounded nuclear norm regularization
  publication-title: Briefings Bioinforma.
  doi: 10.1093/bib/bbac240
– volume: 276
  start-page: 133825
  ident: B34
  article-title: MultiCBlo: enhancing predictions of compound-induced inhibition of cardiac ion channels with advanced multimodal learning
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2024.133825
– volume: 10
  start-page: 2064
  year: 2023
  ident: B48
  article-title: The emerging role of snoRNAs in human disease
  publication-title: Genes and Dis.
  doi: 10.1016/j.gendis.2022.11.018
– start-page: 1
  ident: B49
  article-title: CardiOT: towards interpretable drug cardiotoxicity prediction using optimal transport and Kolmogorov-arnold networks
  publication-title: IEEE J. Biomed. health Inf.
  doi: 10.1109/jbhi.2024.3510297
– volume-title: SBSM-pro: support bio-sequence machine for proteins
  ident: B38
– volume: 26
  start-page: 446
  year: 2021
  ident: B4
  article-title: Predicting miRNA-disease associations based on multi-view variational graph auto-encoder with matrix factorization
  publication-title: IEEE J. Biomed. health Inf.
  doi: 10.1109/JBHI.2021.3088342
– volume: 40
  start-page: btae271
  ident: B55
  article-title: Revisiting drug–protein interaction prediction: a novel global–local perspective
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btae271
– volume: 171
  start-page: 108104
  ident: B39
  article-title: Enhancing drug–food interaction prediction with precision representations through multilevel self-supervised learning
  publication-title: Comput. Biol. Med.
  doi: 10.1016/j.compbiomed.2024.108104
– volume-title: Proceedings of the 30th ACM international conference on information and knowledge management
  year: 2021
  ident: B1
  article-title: Variational graph normalized autoencoders
  doi: 10.1145/3459637.3482215
– volume: 311
  start-page: 230
  year: 2006
  ident: B9
  article-title: The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C
  publication-title: science
  doi: 10.1126/science.1118265
– volume-title: Kan: Kolmogorov-arnold networks
  year: 2024
  ident: B22
– volume: 160
  start-page: 109
  ident: B16
  article-title: Multi-source data integration for explainable miRNA-driven drug discovery
  publication-title: Future Gener. Comput. Syst.
  doi: 10.1016/j.future.2024.05.055
– volume: 15
  start-page: 7681
  ident: B41
  article-title: Efficient deep model ensemble framework for drug-target interaction prediction
  publication-title: J. Phys. Chem. Lett.
  doi: 10.1021/acs.jpclett.4c01509
– volume: 20
  start-page: e1012400
  ident: B36
  article-title: ECD-CDGI: an efficient energy-constrained diffusion model for cancer driver gene identification
  publication-title: PLOS Comput. Biol.
  doi: 10.1371/journal.pcbi.1012400
– volume: 24
  start-page: 742
  year: 2023
  ident: B59
  article-title: StableDNAm: towards a stable and efficient model for predicting DNA methylation based on adaptive feature correction learning
  publication-title: BMC genomics
  doi: 10.1186/s12864-023-09802-7
– volume: 174
  start-page: 108484
  ident: B24
  article-title: Advancing cancer driver gene detection via Schur complement graph augmentation and independent subspace feature extraction
  publication-title: Comput. Biol. Med.
  doi: 10.1016/j.compbiomed.2024.108484
– volume: 11
  start-page: e0162622
  year: 2016
  ident: B12
  article-title: Profiling of small nucleolar RNAs by next generation sequencing: potential new players for breast cancer prognosis
  publication-title: PloS one
  doi: 10.1371/journal.pone.0162622
– volume: 64
  start-page: 2798
  ident: B33
  article-title: An effective plant small secretory peptide recognition model based on feature correction strategy
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/acs.jcim.3c00868
– volume: 6
  start-page: 259
  year: 1989
  ident: B30
  article-title: Analysis of variance (ANOVA)
  publication-title: Chemom. intelligent laboratory Syst.
  doi: 10.1016/0169-7439(89)80095-4
– volume: 12
  start-page: 861
  year: 2011
  ident: B5
  article-title: Non-coding RNAs in human disease
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg3074
– volume: 157
  start-page: 106783
  ident: B43
  article-title: Headtailtransfer: an efficient sampling method to improve the performance of graph neural network method in predicting sparse ncrna–protein interactions
  publication-title: Comput. Biol. Med.
  doi: 10.1016/j.compbiomed.2023.106783
– volume: 14
  start-page: 1170559
  year: 2023
  ident: B18
  article-title: Prediction of miRNA-disease associations in microbes based on graph convolutional networks and autoencoders
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2023.1170559
– volume: 36
  start-page: 2538
  year: 2020
  ident: B13
  article-title: Neural inductive matrix completion with graph convolutional networks for miRNA-disease association prediction
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btz965
– volume: 9
  start-page: 4
  year: 2023
  ident: B15
  article-title: Integration of single sample and population analysis for understanding immune evasion mechanisms of lung cancer
  publication-title: NPJ Syst. Biol. Appl.
  doi: 10.1038/s41540-023-00267-8
– volume: 40
  start-page: btae438
  ident: B23
  article-title: GraphADT: empowering interpretable predictions of acute dermal toxicity with multi-view graph pooling and structure remapping
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btae438
– volume: 9
  start-page: 788
  year: 2019
  ident: B37
  article-title: Identification of eight small nucleolar RNAs as survival biomarkers and their clinical significance in gastric cancer
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2019.00788
SSID ssj0000399364
Score 2.375907
Snippet Existing studies indicate that dysregulation or abnormal expression of small nucleolar RNA (snoRNA) is closely associated with various diseases, including lung...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1529128
SubjectTerms artificial intelligence (AI)
lung cancer
Pharmacology
redevelopment of traditional medicines
snoRNA therapeutic targets
variational graph autoencoder (VGAE)
Title Accurate identification of snoRNA targets using variational graph autoencoder to advance the redevelopment of traditional medicines
URI https://www.ncbi.nlm.nih.gov/pubmed/39834830
https://www.proquest.com/docview/3157556559
https://pubmed.ncbi.nlm.nih.gov/PMC11743687
https://doaj.org/article/c553efc486264dfca34df3bbee44c6bc
Volume 15
WOSCitedRecordID wos001399371700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWg4sAF8U0oVEZCvdCocew49nFBrTjAaoUK2lvk2BO6EkqqTbZSL1z6x5lJsl8IwYVLDkmcOHmT8Zt4_Iaxt7kHJYRXcVIZH6tUAPrBEomcGvTLoOqnC759yqdTM5_b2U6pL8oJG-SBhxd36rNMQuUVMW8VKu8kbmVZAijldenJ-yLr2Qmmeh9M465WwyoZjMLsaXV16Uj_M1VU8scKKr--MxL1gv1_Ypm_J0vujD7nD9mDkTbyydDdR-wO1I_Z8WzQnb454RfbZVTtCT_ms60i9c0TdjvxfkWaEHwRxuygHhDeVLytmy_TCR8ywltOefDf-TVG0ONfQt5LWnO36hrSvAyw5F3Dx9QBjvSRLyFsM4_okvgAYTG2Xs_dt0_Z1_Oziw8f47H6QuwxZO5irYPSISlLBxXSAkAIvQGReA3aZQo8OGtSSK22mfFCBRuscpWWuUBnbkA-Ywd1U8MLxhGwKuQgjXFBmTRYJGUBfUXqROIwYoqYWCNR-FGanCpk_CgwRCH0ih69gtArRvQi9m7T5moQ5vjr2e8J4M2ZJKrd70BTK0ZTK_5lahF7szaPAj9CmllxNTSrtpACWS9S48xG7PlgLptbSWukMjKJmNkzpL2-7B-pF5e90LegcFGb_OX_6P0hu59S7WL6faRfsYNuuYLX7J6_7hbt8ojdzefmqP-IcPv559kvqRUpDA
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accurate+identification+of+snoRNA+targets+using+variational+graph+autoencoder+to+advance+the+redevelopment+of+traditional+medicines&rft.jtitle=Frontiers+in+pharmacology&rft.au=Wang%2C+Zhina&rft.au=Chen%2C+Yangyuan&rft.au=Ma%2C+Hongming&rft.au=Gao%2C+Hong&rft.date=2025-01-06&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=15&rft.spage=1529128&rft_id=info:doi/10.3389%2Ffphar.2024.1529128&rft_id=info%3Apmid%2F39834830&rft.externalDocID=39834830
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon